7 results
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Summary of Recommendations ... Aspergillosis - IDSA ... #pharmacology #dosing ... #medications #IDSA
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
Summary of dosing ... Diabetes #Diabetic #Medications ... #Pharmacology #Dosing ... #Dosing #Renal ... Impairment #CKD #Table
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... #diabetes #medications ... #table #comparison ... #management #endocrinology
Summary of Pharmacology for Select Proposed COVID-19 Treatments

#Pharmacology #Dosing #Table #COVID19 #Coronavirus #SARSCOV2 #Medications #JAMA
Summary of Pharmacology ... #Pharmacology #Dosing ... #Table #COVID19 ... Coronavirus #SARSCOV2 #Medications
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... take any other medications ... #Pharmacology #Endocrinology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Prophylaxis): Indications ... please refer to Table ... 5 for dosing recommendation ... AviumComplex #MAC #IDSA
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... prevent TB disease) Indications ... Please refer to the table ... Guidelines for dosing ... Tuberculosis #TB #IDSA